High materiality7/10
Barclays Double Downgrades Cellectis (CLLS) to Underweight
Why it may matterVerify against the original reporting
Bearish setup driven by downgrade.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
CLLS downgraded to Underweight by Barclays; target $1.3; price $1.61.
- Underweight; target $1.3; price $1.61
Key facts
- 01
Target: $1.3
- 02
Posted price: $1.61
- 03
Analyst firm: Barclays
- 04
Analyst: Lukas Shumway
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.